Patent application number | Description | Published |
20140355578 | Wireless Access Points Providing Hybrid 802.11 and Scheduled Priority Access Communications - Wireless access points providing hybrid 802.11 and scheduled priority access communications are provided herein. An exemplary wireless access point may be configured to communicate with a set of standard access clients using an 802.11 mode of communication during standard access phases, as well as communicate with a set of priority access clients during priority access phases, when the wireless access point is not communicating with the set of standard access clients, using a priority mode of communication. | 12-04-2014 |
20140355584 | Wireless Access Points Providing Hybrid 802.11 and Scheduled Priority Access Communications - Wireless access points providing hybrid 802.11 and scheduled priority access communications are provided herein. An exemplary wireless access point may be configured to communicate with a set of standard access clients using an 802.11 mode of communication during standard access phases, as well as communicate with a set of priority access clients during priority access phases, when the wireless access point is not communicating with the set of standard access clients, using a priority mode of communication. | 12-04-2014 |
20150319584 | Wireless Access Points Providing Hybrid 802.11 and Scheduled Fixed Access Communications - Wireless access points providing hybrid 802.11 and scheduled priority access communications are provided herein. An exemplary wireless access point may be configured to communicate with a set of standard access clients using an 802.11 mode of communication during standard access phases, as well as communicate with a set of priority access clients during priority access phases, when the wireless access point is not communicating with the set of standard access clients, using a priority mode of communication. | 11-05-2015 |
Patent application number | Description | Published |
20100075367 | Lung cancer detection by optical analysis of body fluids - The method for lung cancer detection by optical analysis of body fluids relates to analyzing samples of blood, urine and sputum by fluorescence spectroscopy in order to detect the presence of naturally occurring molecules in the fluids that serve as biomarkers indicative of cancer in the human body. The analysis can be carried out based on fluorescence emission spectra, fluorescence excitation spectra and synchronous (emission and excitation) spectra of bio-samples. The early detection and diagnosis of lung cancer may be made by comparison of ratios of fluorescence emissions and/or excitation intensities of tryptophan, tyrosine, elastin, collagen, bile pigments, NADPH, flavins and various species of porphyrins. | 03-25-2010 |
20100173350 | Method for discriminating between benign and malignant prostate tumors - The method for discriminating between benign and malignant prostate tumors relates to analyzing samples of blood, urine and tissue by fluorescence spectroscopy in order to detect the presence of naturally occurring molecules in the fluids and tissue that serve as biomarkers indicative of cancer in the human body. The analysis can be carried out based on fluorescence emission spectra, fluorescence excitation spectra and synchronous (emission and excitation) spectra of bio-samples. The detection, diagnosis, and follow-up and also discrimination between malignant and benign prostate tumors may be made by comparison of ratios of fluorescence emissions and/or excitation intensities of tryptophan, tyrosine, elastin, collagen, bile pigments, NADH, flavins and various species of porphyrins. | 07-08-2010 |
20140140889 | METHOD FOR ENHANCING THE SHELF LIFE OF DONOR BLOOD BY LASER BIOSTIMULATION - A method for increasing the shelf life of donor blood contemplates the following steps. In the first step blood is transferred to a sterile container and mixed with an anticoagulant as indicated in step | 05-22-2014 |
20140332697 | METHOD OF DETECTING THALASSEMIA BY OPTICAL ANALYSIS OF BLOOD COMPONENTS - The method of detecting thalassemia by optical analysis of blood components is a spectral detection method that is based on the fluorescence spectra of a set of biomolecules, including tyrosine, tryptophan, nicotinamide adenine dinucleotide, and flavin adenine dinucleotide, which are all found in blood plasma, and porphyrin, which is found in red blood cells (RBCs). Measured ratios of intensity maxima between tryptophan and nicotinamide adenine dinucleotide, flavin adenine dinucleotide and nicotinamide adenine dinucleotide, tyrosine and tryptophan, and the normal form of porphyrin and the basic form of porphyrin may each be used, alone or in combination, to diagnose a patient as suffering from thalassemia. | 11-13-2014 |